suggest that, rather than acting as a homophilic adheboth wild-type and NCAM 180 null junctions supsion molecule, the 180 isoform of NCAM may act via ported this pathway, and serine phosphorylation of signaling or direct protein-protein interactions to orga-KENESKA was critical. We propose that this pathway nize presynaptic release machinery that is required to is required to replenish synaptic vesicles utilized dursustain effective transmission with repetitive stimulaing high levels of exocytosis by facilitating myosintion. This prompted us to undertake a bioinformatical driven delivery of synaptic vesicles to active zones or characterization of the intracellular domain of NCAM. their subsequent exocytosis.
extracellular domains, the 180 kDa isoform contains an troduction of peptides that can block specific interactions into the adult NMJ allow one to assess their additional 267 amino acid long alternatively spliced insert (residue 810-1076) encoded by exon 18 (Cunningimpact on multiple aspects of mature functional transmission in a physiologically intact setting. In addition, ham et al., 1987), and its sequence varies more between species. The cytoplasmic sequence of NCAM the introduction of phosphopeptides would allow one to probe the importance of the phosphorylation state has a high content of hydrophilic (50%), charged (21%), and proline (14%) residues, the latter being observed in of various proteins in mediating specific effects. We therefore surveyed several methods based on the Tat many synaptic proteins (Kay et al., 2000) . Few secondary structures, such as α-helix, β sheet, or random coil, or antennapedia means of getting peptides into cells (Kabouridis, 2003) and found that a commercially availwould be predicted within the cytoplasmic tail due to the high content of proline and charged hydrophilic resable product, Chariot (Active Motif, Carslbad, CA), allowed us to effectively introduce peptides into adult idues. This implies that the cytoplasmic domain has an extended, exposed structure that could provide multiNMJs. Following dissection of semitendinosus muscles from ple protein interaction sites. Within the 180-specific domain, we identified several sequences (871-893, adult wild-type P30-P40 mice, an extensive electrophysiological characterization of functional transmis-930-970) with high similarities to cytoskeleton binding proteins. Indeed, a recent study has reported interacsion was carried out at physiological Ca 2+ levels according to previously described protocols ( out at concentrations in an appropriate part of the effective high-frequency transmission and that serine phosphorylation is critical. None of the introduced pepdose-response curve (3 g for KENESKA) and that they were therefore likely to be in the physiological range.
tides had any effects on basic transmission parameters to single stimuli ( Figure 3A) . We propose that introducThe fact that such failures were only found at high stimulus repetition rates but that all transmission parametion of the exogenous KENESKA peptide into the junction interferes with the normal function/protein interacters were normal to single stimuli showed that the overall health of the junctions was maintained and that tions of the KENESKA domain on NCAM and thus mimics the transmission defects when this domain is basic exo-and endocytosis of vesicles was occurring normally. As in the 180 null NMJs, defects only became lacking in either the NCAM null or 180 isoform-specific null NMJ. apparent when junctions were challenged at high stimulus repetition rates. Previously we found that introducThe unusual total transmission failures could occur if there were intermittent branch point failures in the tion of the larger NCAM-derived ATQTKENESKA peptide produced similar results as the KENESKA peptide conduction of action potentials with resultant failure of the presynaptic terminals to be depolarized. Since (data not shown).
The KENESKA domain has a putative serine phosmouse NMJs are not actively invaded by the action potential but electrotonically depolarized by currents from phorylation site, although the kinases that might phosphorylate this site in vivo are unknown. To assess the last node or hemi-node, it is possible to record the various currents, including that of Ca 2+ influx in the terwhether the phosphorylation of this site affected the ability of the peptide to alter high-frequency transmisminal, by extracellular epineural recordings (Brigant and Mallart, 1982 Figures 3B and 3C , middle panels, to Figure 1A ). Replacement of the serine with an asparon KENESKA-treated wild-type NMJs. Following the stimulus artifact, a fast sodium and slower potassium tate, which should mimic phosphorylation of this site, produced a similar amount of transmission failures (Figcurrent were recorded (Figure 3D , arrows). During a 100 Hz train, during which multiple total transmission failure 3B, right panel) as did the phosphorylated KEN ESKA peptide. However, when the serine was replaced ures were always detected in the KENESKA-treated terminal ( Figures 3B and 3C ), there were no alterations in by a glycine (KENEGKA), which is unable to be phosphorylated, there was no effect on transmission even these currents ( Figure 3F ). When the Ca 2+ -activated K + current was blocked with 3,4-diaminopyridine, a peak at 200 Hz ( Figure 3C, right panel) . This result also served as a control for nonspecific effects of the introthat represents the Ca 2+ current and which was completely blocked by cadmium (data not shown) was reduced peptide. In addition, introduction of a scrambled peptide, CSNKATAETKQE, also was without effect vealed ( Taken together the data strongly suggest a specific in the size of this current during a 100 Hz train, there were no large reductions ( Figure 3G ) that could account effect of the KENESKA domain on NCAM in sustaining Figure 4D ), the transmuscle isoform" and a "nonmuscle isoform." The smooth muscle isoform has been studied extensively mission failures observed at high stimulus rates were completely prevented. To ensure that our designed since it is a major regulator of smooth muscle contraction. (Somlyo and Somlyo, 2003) . We therefore per-4A and 4B). The MLCK inhibitory peptide had no effect on quantal content, MEPP frequency or amplitude, or formed Western blots of the PC12 cell lysates at 5 min after stimulation using an antibody that specifically recdepression ( Figure 4C) . Thus, as with the KENESKA peptide, failures in transmission were only detected ognizes serine 19 and threonine 18 on MLC when they are phosphorylated. Figure 4E shows that there is a with repetitive stimulation.
These results suggest that transmission may be imbaseline level of phosphorylation that occurs even in the unstimulated cells (lane 1). Five minutes following paired at junctions that lack all or only the 180 isoform of NCAM, because MLCK is not appropriately actithe 55 mM K + stimulation, phosphorylation was still somewhat increased over the baseline values (lane 2). vated. If true, one would predict that constitutively activating MLCK would rescue the transmission defects in However, introduction of the peptide to make MLCK constitutively active resulted in a 3-fold increase in NMJs that lack NCAM. Indeed, when we introduced a peptide that we designed to interact with MLCK, inducphosphorylation in both the unstimulated and stimulated cells (lanes 3 and 4, respectively). There was no ing a conformation to make MLCK constitutively active duced no failures when applied alone, was applied first. The Effects of MLCK on Transmission May Be Mediated by Its Phosphorylation As expected, no failures were produced, but the subsequent application of the KENESKA peptide resulted in of Myosin Light Chain As noted earlier, MLCK regulates MLC via phosphoryla-45 ± 11 (n = 7) failures during a 100 Hz train, which was not significantly different from 38 ± 5 failures that had tion of serine 19/threonine 18. Figure 7A (top left pair) shows that an antibody that recognizes MLC when been found previously when KENESKA was applied alone. Taken together these observations provide eviboth of these residues are phosphorylated causes strong punctate immunostaining in control wild-type dence that the effect of the KENESKA peptide, and thus we infer of this domain of NCAM, in preventing transNMJs. Furthermore, such immunostaining was greatly decreased in NMJs into which the KENESKA peptide mission failures with high-frequency repetitive stimulation, is mediated primarily through MLCK.
had been introduced 1 hr before (top right pair). Quan- observed result from a presynaptic site of action. In summary, these data make a strong case for a pathway in which the KENESKA domain of NCAM meDiscussion diates the activation of MLCK. This in turn regulates MLC, which is required for effective transmission at high stimulus rates. We speculate that one of the nonPrevious studies from this laboratory discovered a role for NCAM, specifically its 180 kDa isoform, in maintainmuscle myosins is the downstream target of this path- We have now identified a highly conserved stream activation of MLCK. The fact that the KENESKA peptide was without effect in NCAM 180 null NMJs and intracellular domain on NCAM that mediates these effects, and we provide substantial evidence that it acts that a scrambled peptide or one in which the serine had been replaced with glycine was also without effect by allowing sufficient MLCK activation; this in turn we speculate is required for myosin II-driven movements pointed to the specificity of these interactions and the importance of serine phosphorylation in regulating needed to replenish synaptic vesicles used during high-frequency stimulation. Introduction of the KEN these effects of NCAM. The latter conclusion was strengthened by the fact that introduction of the serine ESKA peptide, which corresponds to the C-terminal portion of this conserved domain, into adult +/+ mouse phosphorylated KENESKA or one in which serine was replaced by an aspartate, mimicking a phosphorylated NMJs produced transmission failures similar to those seen in the NCAM 180 null mouse. In contrast, this pepamino acid at this site, produced even more abundant transmission failures, closely approximating the 180 tide had no effect on transmission in NMJs that lacked the 180 kDa NCAM isoform. The ability of NCAM to act null phenotype. We suggest that the binding of this domain to an intracellular PDZ-like binding partner is regas a signaling molecule has been increasingly appreciated ( In summary, while more work will be needed to deterWhile we cannot be certain that the observed mine which myosins (myosin IIA or IIB) are involved in changes in phosphorylation of this site on MLC were transmission at adult mouse NMJ as well as to eluciresponsible for the alterations in transmission prodate their precise roles in synaptic vesicle movement duced by the various peptides alone or in combination, and exocytosis required to maintain effective high-frethe data clearly indicate that introduction of the KEN quency transmission, it seems very likely that the path-ESKA peptide was able to bring about a biochemical way we have described involving the KENESKA domain change in MLC at this site consistent with the effects of the 180 isoform of NCAM will play an essential role. we observed on transmission. Taken together our data The present study has also shown that it is possible to suggest that the ultimate downstream target of the introduce peptides via a peptide carrier into the junc-KENESKA domain of NCAM in mediating effective tions of adult, acutely isolated muscles and that this transmission is likely to be one of the nonmuscle myomethod can be used to probe specific protein- 
